Status:
COMPLETED
Paracervical Block in First Trimester Surgical Abortions
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
Pain
Surgical Abortion
Eligibility:
FEMALE
18-50 years
Phase:
PHASE2
PHASE3
Brief Summary
The investigators primary objective is to study the analgesic effects of combined ketorolac and lidocaine in a paracervical block compared to preoperative ibuprofen followed by intra-operative paracer...
Eligibility Criteria
Inclusion
- age greater than or equal to 18 years
- English-speaking
- ability and willingness to sign the informed consent
- ability and willingness to comply with the terms of the study
- voluntary request for pregnancy termination
- ultrasound-confirmed singleton intrauterine pregnancy with an estimated gestational age not exceeding 76 days (10 6/7 weeks) from the first day of the preceding menstrual cycle
Exclusion
- women who require or request sedation
- untreated acute cervicitis or pelvic inflammatory disease
- contraindications to lidocaine such as allergy to lidocaine, cardiac arrhythmia or heart block, and porphyria
- allergic reaction or sensitivity to lorazepam or NSAIDs
- chronic NSAID use
- history of gastritis or gastric ulcer
- acute renal failure or chronic renal disease
- chronic liver disease
- history of bleeding diathesis
- chronic narcotic use
- current or past history of illegal drug use (excluding marijuana)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00617097
Start Date
January 1 2008
End Date
June 1 2009
Last Update
September 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood Columbia-Willamette
Portland, Oregon, United States, 97239